[Correspondence] Low procalcitonin, community acquired pneumonia, and antibiotic therapy

Our concerns about the meta-analysis of procalcitonin-guided therapy in patients with acute respiratory infections by Philipp Schuetz and colleagues1 go well beyond those expressed in an accompanying Comment.2 We fear that physicians will infer that antibiotic treatment can be given to or withheld from patients with community-acquired pneumonia on the basis of plasma procalcitonin concentrations.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research